The injected Zepbound® produced a total of 38 adverse ... Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any ...

The injected Zepbound® produced a total of 38 adverse ... Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any ...

The injected Zepbound® produced a total of 38 ... Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation ...

"Sales of Mounjaro and Zepbound posted robust sales growth ... estimates based on information available as of the date of this press release and has been prepared by company management.

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

The Indianapolis, Indiana-based company is set to release its Q4 earnings on Tuesday ... by inventory decreases at wholesalers, impacting Zepbound and Mounjaro sales despite strong year-over ...